Exacerbation of pathogenic Th17-cell-mediated cutaneous graft-versus-host-disease in human IL-1β and IL-23 transgenic humanized mice

Biochem Biophys Res Commun. 2019 Aug 20;516(2):480-485. doi: 10.1016/j.bbrc.2019.06.094. Epub 2019 Jun 20.

Abstract

Although Th17 cells are closely linked to cutaneous graft-versus-host-disease (GVHD) in mouse models, this association remains unclear in human GVHD. In this study, we established a novel xenogeneic cutaneous GVHD model using humanized mice. To induce the differentiation of human Th17 cells, we created transgenic NOG mice expressing human IL-1β and IL-23 cytokines (hIL-1β/23 Tg) and transplanted with human CD4+ T cells. The pathologies of cutaneous GVHD, such as a decrease in body weight, alopecia, and T cell inflammation in the skin, were observed much earlier in hIL-1β/23 Tg mice compared with non-Tg mice after human CD4+ T cell transplantation. In the skin of Tg mice, IL-17- and IFNγ-producing pathogenic Th17 cells were significantly accumulated. Furthermore, high infiltration of murine neutrophils was seen in the skin of Tg mice, but not non-Tg mice, which may have been the cause of the severe alopecia. CD4+ T-cell-transferred hIL-1β/23 Tg mice were therefore highly sensitive models for inducing cutaneous GVHD mediated by human pathogenic Th17 cells.

Keywords: Cutaneous GVHD; Humanized mice; Pathogenic Th17 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Progression*
  • Graft vs Host Disease / immunology*
  • Graft vs Host Disease / pathology*
  • Humans
  • Interferon-gamma / metabolism
  • Interleukin-1beta / metabolism*
  • Interleukin-23 / metabolism*
  • Lymphocyte Count
  • Mice, Transgenic
  • Skin Transplantation / adverse effects*
  • Th17 Cells / pathology*

Substances

  • IL1B protein, human
  • Interleukin-1beta
  • Interleukin-23
  • Interferon-gamma